Skip to content
Evexia Lifecare logo

Evexia Lifecare

524444 BSE
₹1.46

Close ·

P/E
Not meaningful: loss-making over the last twelve months
View as Markdown
MCP
Close 4 Nov 2026 ₹1.46 −0.32 −18.0% 1Y
Start ₹1.78

Key Fundamentals

MicrocapConsumer GoodsFMCG

Price-based figures at the close · EPS basis: Consolidated · TTM

ROCE
—
Debt to Equity
2.16
EPS (TTM)
₹0.00
Book Value
₹2.14
Market Cap
—
P/E (TTM)
Not meaningful: loss-making over the last twelve months
P/B
0.68
ROE
—
Dividend Yield
0.00%
EBITDA
₹2.87 Cr
52W High
₹2.28
52W Low
₹0.47

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

51 Average

Data confidence 95/100

Category scores

Quality
28
Poor
Returns, margins, earnings quality 22% weight
Valuation
39
Weak
Cheap vs sector & own history 24% weight
Growth
69
Strong
Sales & profit trajectory 9% weight
Financial Health
43
Weak
Solvency, leverage, coverage 9% weight
Momentum
74
Strong
Trend strength, vol-adjusted 12% weight
Ownership
66
Good
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Stock is trading at 0.66 times its book value
  • Company is expected to give good quarter

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 3.36%
  • Earnings include an other income of Rs.0.94 Cr.
  • Promoter holding has decreased over last 3 years: -6.51%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1216
OscillatorsStrong Bullish216
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
29.35
Bullish
MACD (12,26,9)
−0.09
Bearish
SMA (50)
1.74
Bearish
SMA (200)
1.48
Bearish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+12.46%
5Y+0.55%
3Y+16.26%
1Y+26.44%
TTM+26.08%

Net profit

Net profit growth by window
10YZero base
5Y+14.87%
3Y+25.99%
1YZero base
TTM−7.00%

Operating cash flow

Operating cash flow growth by window
10YTurned negative
5YTurned negative
3YOutflow widened by ₹20 Cr
1YOutflow widened by ₹21 Cr
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+2.73 pp
5Y+70.02 pp
3Y+1.30 pp
1Y+0.43 pp
TTM−2.21 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹178 Cr
Mar 2018₹74.00 Cr
Mar 2019₹105 Cr
Mar 2020₹100 Cr
Mar 2021₹107 Cr
Mar 2022₹76.00 Cr
Mar 2023₹70.00 Cr
Mar 2024₹56.00 Cr
Mar 2025₹87.00 Cr
Mar 2026₹110 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹1.00 Cr
Mar 2018₹0.00 Cr
Mar 2019₹2.00 Cr
Mar 2020₹3.00 Cr
Mar 2021₹1.00 Cr
Mar 2022₹1.00 Cr
Mar 2023₹1.00 Cr
Mar 2024₹1.00 Cr
Mar 2025₹0.00 Cr
Mar 2026₹2.00 Cr

Quarterly Results

₹ Cr
524444 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
14.02
10.65
6.75
24.72
21.23
26.71
21.7
23.61
22.09
25.73
25.24
36.79
30.89
Expenses
13.83
12.01
6.76
21.66
20.93
25.62
21.53
22.29
21.01
25.63
24.99
35.69
30.35
Operating Profit
0.19
−1.36
−0.01
3.06
0.3
1.09
0.17
1.32
1.08
0.1
0.25
1.1
0.54
OPM %
1.36%
−12.77%
−0.15%
12.38%
1.41%
4.08%
0.78%
5.59%
4.89%
0.39%
0.99%
2.99%
1.75%
Other Income
0.2
−0.2
0
0.86
0.13
0
0.1
0
0
0.43
0.26
0.1
0.15
Interest
0
0.01
−0.01
0.49
0
0.05
0
0.41
0.01
0
0
0
0.01
Depreciation
0.1
0.1
0.07
0.15
0.1
0.11
0.11
0.46
0.21
0.03
0.12
0.3
0.11
PBT
0.29
−1.67
−0.07
3.28
0.33
0.93
0.16
0.45
0.86
0.5
0.39
0.9
0.57
Tax %
27.59%
0%
−28.57%
16.77%
24.24%
0%
25%
31.11%
25.58%
28%
25.64%
13.33%
26.32%
Net Profit
0.22
−1.67
−0.05
2.73
0.24
0.94
0.12
0.31
0.63
0.37
0.29
0.78
0.42
EPS (₹)
0
−0.03
0
0.04
0
0.01
0
0
0
0
0
0
0

Profit & Loss

₹ Cr
524444 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
1
34
178
74
105
100
107
76
70
56
87
110
119
Expenses
1
34
176
74
106
107
179
73
69
54
85
107
117
Operating Profit
0
0
1
0
−1
−6
−72
2
1
2
2
3
2
OPM %
−8%
−0.3%
0.7%
−0.5%
−0.8%
−6%
−68%
3.2%
0.8%
3.5%
1.9%
2.6%
1.7%
Other Income
0
1
0
1
3
12
74
0
2
1
0
0
1
Interest
0
0
0
0
0
0
0
0
1
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
1
1
PBT
0
0
1
1
2
5
2
2
2
2
1
2
2
Tax %
31%
41%
32%
33%
30%
29%
33%
60%
56%
28%
55%
26%
—
Net Profit
0
0
1
0
2
3
1
1
1
1
0
2
2
EPS (₹)
0
0
0.01
0.01
0.03
0.06
0.02
0.01
0.01
0.02
0
0.01
0
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
524444 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
46
62
62
62
62
62
62
62
66
71
188
188
Reserves
19
3
4
11
13
16
18
19
24
59
272
379
Borrowings
5
11
6
6
4
7
7
6
705
686
386
1,222
Other Liabilities
4
35
147
128
146
139
56
41
52
67
75
65
Total Liabilities
74
112
219
208
224
224
142
127
848
883
920
1,853
Fixed Assets
2
2
2
9
9
9
9
9
11
11
50
14
CWIP
0
0
0
0
0
0
0
2
0
0
0
1
Investments
4
1
1
0
0
0
1
1
704
724
717
879
Other Assets
68
109
216
199
216
215
132
115
132
148
154
959
Total Assets
74
112
219
208
224
224
142
127
848
883
920
1,853

Cash Flow

₹ Cr
524444 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
4
11
−116
−12
0
−3
2
−6
−3
17
−2
−23
Investing
0
2
1
−6
0
1
−2
8
−697
−17
−18
53
Financing
−4
−12
113
18
0
2
1
−1
699
1
20
−28
Net Cash Flow
1
1
−2
0
0
0
0
1
−1
0
0
2
Free Cash Flow
4
11
−116
−18
0
−3
2
−8
−6
17
−2
−27
CFO/OP
−8,200
−9,864
−9,145
3,357
−44
52
−3
−152
−184
910
−194
−818

Ratios

524444 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
983
237
286
174
197
249
156
73
164
282
392
—
Inventory Days
197
5
2
3
3
2
12
7
11
8
12
—
Days Payable
187
384
73
67
158
172
114
124
186
195
280
—
Cash Conversion Cycle
993
−142
215
109
42
80
54
−44
−11
95
123
—
Working Capital Days
−1,578
248
250
278
134
245
192
175
207
343
143
—
ROCE %
—
0%
2%
1%
3%
6%
2%
3%
0%
0%
0%
—

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Evexia Lifecare insights

58 extracted metrics across FY09–FY27.

Shareholding Pattern

As of Sep 2026

  • Public 55.83%
  • Others 35.49%
  • Promoters 8.60%
  • DIIs 0.08%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Evexia Lifecare

What does Evexia Lifecare Ltd do?
Incorporated in 1990, Evexia Lifecare Ltd does trading of Chemicals, Agriculture Produce and other Consumer Goods
Where is Evexia Lifecare Ltd (EVEXIA) listed?
Evexia Lifecare Ltd trades under code 524444 on the BSE.
Which sector does Evexia Lifecare Ltd belong to?
Evexia Lifecare Ltd is classified under the FMCG sector, in the FMCG Products industry.
What is the 52-week high and low of Evexia Lifecare Ltd?
Over the last 52 weeks Evexia Lifecare Ltd has traded between ₹0.47 and ₹2.28 as of 4 Nov 2026.

Company Information

Incorporated in 1990, Evexia Lifecare Ltd does trading of Chemicals, Agriculture Produce and other Consumer Goods

Website evexialifecare.com
Face Value ₹1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524444.md for Evexia Lifecare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month